×
About 1,900 results

ALLMedicine™ Lymphoblastic Lymphoma Center

Research & Reviews  937 results

Anaplastic diffuse large B-cell lymphoma cytologically diagnosed in pleural effusion: R...
https://doi.org/10.1002/dc.24730
Diagnostic Cytopathology; AbdullGaffar B, Seliem R

Feb 25th, 2021 - Diffuse large B-cell lymphoma (DLBCL) has some rare special subtypes. Anaplastic variant has the immunophenotypic and genotypic features of DLBCL, and is characterized by the presence of large bizarre hallmark-like and Reed-Sternberg-Hodgkin-like ...

B-Lymphoblastic Lymphoma of the Small Bowel: An Extremely Rare Occurrence.
https://doi.org/10.1177/0003134821998679
The American Surgeon; Symeonidis NG, Stavrati KE et. al.

Feb 25th, 2021 - B-lymphoblastic lymphoma is a neoplasm of immature B cells and is characterized by aggressive behavior and disease progression. Common sites of involvement are skin, lymph nodes, bone, soft tissues, breast, and the mediastinum. Gastrointestinal le...

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or...
https://doi.org/10.1158/2159-8290.CD-20-1465
Cancer Discovery; Pullarkat VA, Lacayo NJ et. al.

Feb 17th, 2021 - Combining venetoclax, a selective BCL-2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL-2 inhibitor, may allow targeting of both BCL-2 and BCL XL without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preli...

B-cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years.
https://doi.org/10.1111/tbj.14176
The Breast Journal; Oral H, Turkyilmaz Z et. al.

Feb 2nd, 2021 - B-cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years.|2021|Oral H,Turkyilmaz Z,Arslan Kahraman Dİ,Kaya C,Karabulut R,|

Retracted The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864005
International Journal of Oncology; Fan FY, Deng R et. al.

Jan 25th, 2021 - Following the publication of this paper, it was drawn to the authors' attention by an interested reader that a row of the tumour images featured in Fig. 8A of the above paper were strikingly similar to those featured in Fig. 6A of an article appea...

see more →

Guidelines  1 results

Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagn...
https://academic.oup.com/annonc/article/27/suppl_5/v69/1741378
Hoelzer, D.

Apr 6th, 2016 - The estimated overall incidence of acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma in Europe is 1. 28 per 100 000 individuals annually, with significant age-related variations (0.

see more →

Drugs  2 results see all →

Clinicaltrials.gov  953 results

Anaplastic diffuse large B-cell lymphoma cytologically diagnosed in pleural effusion: R...
https://doi.org/10.1002/dc.24730
Diagnostic Cytopathology; AbdullGaffar B, Seliem R

Feb 25th, 2021 - Diffuse large B-cell lymphoma (DLBCL) has some rare special subtypes. Anaplastic variant has the immunophenotypic and genotypic features of DLBCL, and is characterized by the presence of large bizarre hallmark-like and Reed-Sternberg-Hodgkin-like ...

B-Lymphoblastic Lymphoma of the Small Bowel: An Extremely Rare Occurrence.
https://doi.org/10.1177/0003134821998679
The American Surgeon; Symeonidis NG, Stavrati KE et. al.

Feb 25th, 2021 - B-lymphoblastic lymphoma is a neoplasm of immature B cells and is characterized by aggressive behavior and disease progression. Common sites of involvement are skin, lymph nodes, bone, soft tissues, breast, and the mediastinum. Gastrointestinal le...

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or...
https://doi.org/10.1158/2159-8290.CD-20-1465
Cancer Discovery; Pullarkat VA, Lacayo NJ et. al.

Feb 17th, 2021 - Combining venetoclax, a selective BCL-2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL-2 inhibitor, may allow targeting of both BCL-2 and BCL XL without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preli...

B-cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years.
https://doi.org/10.1111/tbj.14176
The Breast Journal; Oral H, Turkyilmaz Z et. al.

Feb 2nd, 2021 - B-cell lymphoblastic lymphoma of unilateral primary breast mass in a boy aged 11 years.|2021|Oral H,Turkyilmaz Z,Arslan Kahraman Dİ,Kaya C,Karabulut R,|

Retracted The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864005
International Journal of Oncology; Fan FY, Deng R et. al.

Jan 25th, 2021 - Following the publication of this paper, it was drawn to the authors' attention by an interested reader that a row of the tumour images featured in Fig. 8A of the above paper were strikingly similar to those featured in Fig. 6A of an article appea...

see more →

News  7 results

Promising early efficacy of venetoclax/navitoclax in r/r acute lymphoblastic leukemia
https://www.mdedge.com/hematology-oncology/article/215564/all/promising-early-efficacy-venetoclax/navitoclax-r/r-acute?channel=39313
Neil Osterweil

Jan 15th, 2020 - ORLANDO – A combination of venetoclax (Venclexta) and the experimental BCL-2 inhibitor navitoclax showed good activity and acceptable safety in both children and adults with relapsed or refractory acute lymphoblastic leukemia or lymphoblastic lymp.

SC-PEG comparable to pegaspargase in young ALL/LL patients
https://www.mdedge.com/hematology-oncology/article/202053/all/sc-peg-comparable-pegaspargase-young-all/ll-patients?channel=39313
Jennifer Smith

Jun 1st, 2019 - CHICAGO – Calaspargase pegol (SC-PEG) produces similar outcomes as standard pegaspargase in pediatric and young adult patients with newly diagnosed acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL), according to a phase 2 trial. Je.

Fast Five Quiz: Test Your Knowledge on Key Aspects of Non-Hodgkin Lymphoma
https://reference.medscape.com/viewarticle/900766

Aug 19th, 2018 - The term "lymphoma" describes a heterogeneous group of cancers with different biology and prognoses. In general, lymphomas are divided into two large groups of neoplasms: non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma. About 85% of all malignant ...

International Approvals: NovoRapid, Fentanyl, Atriance
https://www.medscape.com/viewarticle/563243

Sep 23rd, 2007 - September 24, 2007 -- The European Commission (EC) has approved insulin aspart subcutaneous injection for use in the elderly and patients with renal or hepatic impairment; the Japanese Ministry of Health, Labor, and Welfare has approved fentanyl c...

FDA Approvals: Arranon, Kaletra Tablets, Soltamox
https://www.medscape.com/viewarticle/516058

Nov 2nd, 2005 - Nov. 3, 2005 — The U.S. Food and Drug Administration (FDA) has approved nelarabine intravenous injection for the treatment of T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma in patients who have not responded to or have relapsed aft...

see more →